IL-23: changing the verdict on IL-12 function in inflammation and autoimmunity

Bibliography

• KOBAYASHI M, FITZ L, RYAN M et al: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. I Exp. Med. (1989) 170:827–845.
   PubMed Web of Science ®Google Scholar
• ••This is the original description andcloning of IL-12.
   Google Scholar
• GATELY MK, DESAI BB, WOLITZKY AG et al: Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). Immunol. (1991) 147:874–882.
   Web of Science ®Google Scholar
• GUBLER U, CHUA AO, SCHOENHAUT DS et al: Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA (1991) 88:4143–4147.
   PubMed Web of Science ®Google Scholar
• WOLF SF, TEMPLE PA, KOBAYASHI M et al.: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. (1991) 146:3074–3081.
   PubMed Web of Science ®Google Scholar
• MERBERG DM, WOLF SF, CLARK SC: Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol. Today(1992) 13:77–78.
   PubMedGoogle Scholar
• GEARING DP, COSMAN D: Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell (1991) 66:9–10.
   PubMed Web of Science ®Google Scholar
• SCHOENHAUT DS, CHUA AO, WOLITZKY AG et al: Cloning and expression of murine IL-12. Immunol. (1992) 148:3433–3440.
   Web of Science ®Google Scholar
• TRINCHIERI G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev Immunol. (2003) 3:133–146.
   PubMed Web of Science ®Google Scholar
• ••This review provides a broad overview onthe role of IL-12 in infection and Immunity.
   Google Scholar
• BABIK JM, ADAMS E, TONE Y et al: Expression of murine IL-12 is regulated by translational control of the p35 subunit. Immunol. (1999) 162:4069–4078.
   Web of Science ®Google Scholar
• MAX, TRINCHIERI G: Regulation of interleukin-12 production in antigen-presenting cells. Adv. Immunol. (2001) 79:55–92.
   PubMed Web of Science ®Google Scholar
• MURPHY TL, CLEVELAND MG, KULESZA P, MAGRAM J, MURPHY KM: Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol. Cell Biol. (1995) 15:5258–5267.
   PubMed Web of Science ®Google Scholar
• MAX, CHOW JM, GRI G et al: The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.' Exp. Med. (1996) 183:147–157.
   PubMed Web of Science ®Google Scholar
• MAX, NEURATH M, GRI G, TRINCHIERI G: Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. I Biol. Chem. (1997) 272:10389–10395.
   Google Scholar
• PLEVY SE, GEMBERLING JH, HSU S, DORNER AISMALE ST: Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell Biol. (1997) 17:4572–4588.
   PubMed Web of Science ®Google Scholar
• WANG IM, CONTURSI C, MASUMI A et al: An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J. Immunol. (2000) 165:271–279.
   PubMed Web of Science ®Google Scholar
• TRINCHIERI G, WYSOCKA M, D'ANDREA A et al: Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Frog. Growth Factor Res. (1992) 4:355–368.
   PubMedGoogle Scholar
• MEDZHITOV R: Toll-like receptors andinnate immunity. Nat. Rev Immunol. (2001) 1:135–145.
   PubMed Web of Science ®Google Scholar
• CELLA M, SCHEIDEGGER D, PALMER-LEHMANN K et al.: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. (1996) 184:747–752.
   PubMed Web of Science ®Google Scholar
• BECHER B, BLAIN M, ANTEL JP, YOSHIDA TO: CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Thl polarization in the CNS. j Neuroimmunol. (2000) 102:44–50.
   PubMed Web of Science ®Google Scholar
• FLESCH IE, HESS JH, HUANG S et al: Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J. Exp. Med. (1995) 181:1615–1621.
   PubMed Web of Science ®Google Scholar
• BECHER B, DODELOT V, FED OROWICZ V, ANTEL JP: Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invest. (1996) 98:1529–1543.
   Web of Science ®Google Scholar
• YOSHIDA A, KOIDE Y, UCHIJIMA M, YOSHIDA TO: IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochem. Biophys. Res. Commun. (1994) 198:857–861.
   PubMed Web of Science ®Google Scholar
• GRAN B, ZHANG GX, ROSTAMI A: Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. Crit. Rev. Immunol. (2004) 24:111–128.
   PubMed Web of Science ®Google Scholar
• •This review provides insights into the role of IL-12 and IL-23 in EAE.
   Google Scholar
• HSIEH CS, MACATONIA SE, TRIPP CS et al: Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (1993) 260:547–549.
   PubMed Web of Science ®Google Scholar
• MANETTI R, PARRONCHI P, GIUDIZI MG et al.: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper Type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. (1993) 177:1199–1204.
   PubMed Web of Science ®Google Scholar
• CHUA AO, CHIZZONITE R, DESAI BB et al.: Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. Immunol (1994) 153:128–136.
   Google Scholar
• PRESKY DH, YANG H, MINETTI LJ et al: A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA (1996) 93:14002–14007.
   PubMed Web of Science ®Google Scholar
• WATFORD WT, MORIGUCHI M, MORINOBU A, O'SHEA JJ: The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev (2003) 14:361–368.
   PubMed Web of Science ®Google Scholar
• DESAI BB, QUINN PM, WOLITZKY AG et al: IL-12 receptor. II. Distribution and regulation of receptor expression." Immunol. (1992) 148:3125–3132.
   Google Scholar
• PUCCETTI P, BELLADONNA ML, GROHMANN U: Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity. Grit. Rev Immunol (2002) 22:373–390.
   PubMed Web of Science ®Google Scholar
• ROGGE L, PAPI A, PRESKY DH et al.:Antibodies to the IL-12 receptor beta 2 chain mark human Thl but not Th2 cells in vitro and in vivo. J. Immunol (1999) 162:3926–3932.
   PubMed Web of Science ®Google Scholar
• ZOU J, PRESKY DH, WU CY, GUBLER U: Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases. J. Biol. Chem. (1997) 272:6073–6077.
   PubMed Web of Science ®Google Scholar
• BACON CM, PETRICOIN EF, 3rd, ORTALDO JR et al.: Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Nati Acad. Sci. USA (1995) 92:7307–7311.
   Google Scholar
• JACOBSON NG, SZABO SJ, WEBER-NORDT RM et al.: Interleukin 12 signaling in T helper Type 1 (Thl) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4." Exp. Med. (1995) 181:1755–1762.
   Google Scholar
• COLOMBO MP, TRINCHIERI G: Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev (2002) 13:155–168.
   PubMed Web of Science ®Google Scholar
• NOVELLI F, CASANOVA JL: The role ofIL-12, IL-23 and IFN-gamma in immunity to viruses. Cytokine Growth Factor Rev (2004) 15:367–377.
   PubMed Web of Science ®Google Scholar
• STEINMAN L: Multiple sclerosis: a two-stage disease. Nat. Immunol (2001) 2:762–764.
   PubMed Web of Science ®Google Scholar
• •This review provides an overview on MS and EAE.
   Google Scholar
• TEUNISSEN CE, DIJKSTRA C, POLMAN C: Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol (2005) 4:32–41.
   PubMed Web of Science ®Google Scholar
• NICOLETTI F, PATTI F, COCUZZA C et al.: Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. Neuroimmunol (1996) 70:87–90.
   PubMed Web of Science ®Google Scholar
• DRULOVIC J, MOSTARICA-STOJKOVIC M, LEVIC Z et al.: Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients. J. Neurol. Sci. (1997) 147:145–150.
   PubMed Web of Science ®Google Scholar
• COMABELLA M, BALASHOV K, ISSAZADEH S et al.: Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J. Clin. Invest. (1998) 102:671–678.
   PubMed Web of Science ®Google Scholar
• •An elegant study demonstrating a correlation between IL-12 expression and MS severity.
   Google Scholar
• BOXEL-DEZAIRE AH, HOFF SC, VAN OOSTEN BW et al: Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol (1999) 45:695–703.
   PubMed Web of Science ®Google Scholar
• FASSBENDER K, RAGOSCHKE A, ROSSOL S et al: Increased release of interleukin-12p40 in MS: association with intracerebral inflammation. Neurology (1998) 51:753–758.
   PubMed Web of Science ®Google Scholar
• OZENCI V, PASHENKOV M, KOUWENHOVEN M et al: IL-12/ IL-12R system in multiple sclerosis. Neuroimmunol (2001) 114:242–252.
   Google Scholar
• BEN NUN A, WEKERLE H, COHEN IR: The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. I Immunol (1981) 11:195–199.
   PubMed Web of Science ®Google Scholar
• PETTINELLI CB, MCFARLIN DE: Adoptive transfer of experimental allergic encephalomyelitis in SRA mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+2- T lymphocytes.' Immunol (1981) 127:1420–1423.
   Web of Science ®Google Scholar
• GRETER M, HEPPNER FL, LEMOS MP et al: Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. (2005) 11:328–334.
   PubMed Web of Science ®Google Scholar
• HEPPNER FL, GRETER M, MARINO D et al.: Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. (2005) 11:146–152.
   PubMed Web of Science ®Google Scholar
• DIAB A, ZHU J, XIAO BG, MUSTAFA M, LINK H: High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. J. Neuropathol Exp. Neurol (1997) 56:641–650.
   PubMed Web of Science ®Google Scholar
• ISSAZADEH S, LORENTZEN JC, MUSTAFA MI et al.: Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta. J. Neuroimmunol (1996) 69:103–115.
   PubMed Web of Science ®Google Scholar
• ISSAZADEH S, MUSTAFA M, LJUNGDAHL A et al: Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. Neurosci. Res. (1995) 40:579–590.
   Web of Science ®Google Scholar
• BRIGHT JJ, MUSURO BE DU C, SRIRAM S: Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. Neuroimmunol (1998) 82:22–30.
   Google Scholar
• SMITH T, HEWSON AK, KINGSLEY CI, LEONARD JP, CUZNER ML: Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am. J. Pathol (1997) 150:1909–1917.
   PubMed Web of Science ®Google Scholar
• SEGAL BM, DWYER BK, SHEVACH EM: An interleukin (ID-10/ IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. (1998) 187:537–546.
   PubMed Web of Science ®Google Scholar
• ••An elegant study demonstrating the crucialfunction of IL-12p40 in EAE pathogenesis.
   Google Scholar
• LEONARD JP, WALDBURGER KE, GOLDMAN SJ: Prevention of experimental autoimmune encephalomyelitis by antibodies against 1133 interleukin 12. J. Exp. Med. (1995) 181:381–386.
   PubMed Web of Science ®Google Scholar
• ••The first paper to demonstrate thatanti-IL-12p40 Abs prevent EAE.
   Google Scholar
• MIOSSEC P: An update on the cytokine network in rheumatoid arthritis. Curr. Opin. Rheumatol (2004) 16:218–222.
   PubMed Web of Science ®Google Scholar
• BRAND DD, KANG AH, ROSLONIEC EF: Immunopathogenesis of collagen arthritis. Springer Semin. Immunopathol (2003) 25:3–18.
   PubMed Web of Science ®Google Scholar
• GERMANN T, SZELIGA J, HESS H et al.: Administration of interleukin 12 in combination with Type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA (1995) 92:4823–4827.
   PubMed Web of Science ®Google Scholar
• •This study demonstrates that IL-12 application exacerbates CIA.
   Google Scholar
• MALFAIT AM, BUTLER DM, PRESKY DH et al.: Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Chit. Exp. Immunol (1998) 111:377–383.
   PubMed Web of Science ®Google Scholar
• MCINTYRE KW, SHUSTER DJ, GILLOOLY KM et al: Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur. Immunol (1996) 26:2933–2938.
   PubMed Web of Science ®Google Scholar
• MATTHYS P, VERMEIRE K, MITERA T et al: Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice. Eur. Immunol (1998) 28:2143–2151.
   PubMed Web of Science ®Google Scholar
• VERMEIRE K, HEREMANS H, VANDEPUTTE M et al: Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. I Intmunol. (1997) 158:5507–5513.
   Google Scholar
• ADORINI L, GREGORI S, HARRISON LC: Understanding autoimmune diabetes: insights from mouse models. Trends Mol. Med. (2002) 8:31–38.
   PubMed Web of Science ®Google Scholar
• FALCONE M, SARVETNICK N: Cytokines that regulate autoimmune responses. Curr. Opin. Immunol. (1999) 11:670–676.
   PubMed Web of Science ®Google Scholar
• TREMBLEAU S, GERMANN T, GATELY MK, ADORINI L: The role of IL-12 in the induction of organ-specific autoimmune diseases. Intmunol. Today (1995) 16:383–386.
   PubMedGoogle Scholar
• CHU CQ, WITTMER S, DALTON DK: Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. (2000) 192:123–128.
   PubMed Web of Science ®Google Scholar
• ••This study shows elegantly that the lack ofIFN-y exacerbates EAE and provides the first insights into the mechanistic underpinnings.
   Google Scholar
• FREI K, EUGSTER HP, BOPST M et al: Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. (1997) 185:2177–2182.
   PubMed Web of Science ®Google Scholar
• •This study demonstrates that the TH1 cytokines TNF-a and lymphotoxin-a are not required for EAE development.
   Google Scholar
• WILLENBORG DO, FORDHAM S, BERNARD CC, COWDEN WB, RAMSHAW IA: IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Immunol (1996) 157:3223–3227.
   Web of Science ®Google Scholar
• MATTNER F, MAGRAM J, FERRANTE J et al.: Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. Intmunol. (1996) 26:1553–1559.
   PubMed Web of Science ®Google Scholar
• BECHER B, DURELL BG, NOELLE RJ: Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12.1 Chit. 'nye:v.1- (2002) 110:493-497.
   Google Scholar
• ••This is the first study in the literaturedemonstrating that IL-12 is not required for EAE, but that IL-23p40 is vital.
   Google Scholar
• GRAN B, ZHANG GX, YU S et al: IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. Irnmunol. (2002) 169:7104–7110.
   PubMed Web of Science ®Google Scholar
• ZHANG GX, GRAN B, YU S et al: Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. ./. Immunol (2003) 170:2153–2160.
   PubMed Web of Science ®Google Scholar
• •This study shows that IL-12 receptor-131 and not 132 is important for EAE.
   Google Scholar
• GILLESSEN S, CARVAJAL D, LING P et al: Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. Immunol (1995) 25:200–206.
   PubMed Web of Science ®Google Scholar
• LING P, GATELY MK, GUBLER U et al: Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol (1995) 154:116–127.
   PubMed Web of Science ®Google Scholar
• •This study shows that p40 can homodimerise and act as an IL-12R antagonist.
   Google Scholar
• HA SJ, LEE CH, LEE SB et al: A novel function of IL-12p40 as a chemotactic molecule for macrophages. J. Immunol (1999) 163:2902–2908.
   PubMed Web of Science ®Google Scholar
• HUAUX F, ARRAS M, TOMASI D et al: A profibrotic function of IL-12p40 in experimental pulmonary fibrosis. Immunol (2002) 169:2653–2661.
   Web of Science ®Google Scholar
• LEHMANN J, BELLMANN S, WERNER C et al.: IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis. Immunol (2001) 167:5304–5315.
   Web of Science ®Google Scholar
• LANKFORD CS, FRUCHT DM: A unique role for IL-23 in promoting cellular immunity. J. Leukoc. Biol. (2003) 73:49–56.
   PubMed Web of Science ®Google Scholar
• OPPMANN B, LESLEY R, BLOM B et al: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 13:715–725.
   PubMed Web of Science ®Google Scholar
• ••The initial discovery and cloning of IL-23.
   Google Scholar
• FRUCHT DM: IL-23: a cytokine that actson memory T cells. Sci. STKE (2002) 2002:PEl.
   Google Scholar
• VAN SEVENTER JM, NAGAI T, VAN SEVENTER GA: Interferon-beta differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells. Neuroimmunol (2002) 133:60–71.
   PubMed Web of Science ®Google Scholar
• WESA A, GALY A: Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand. BMC. Immunol (2002) 3:14.
   PubMedGoogle Scholar
• RE F, STROMINGER JL: Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. .1 Biol. Chem. (2001) 276:37692–37699.
   Google Scholar
• PARHAM C, CHIRICA M, TIMANS J et al.: A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbetal and a novel cytokine receptor subunit, IL-23R. J. Immunol (2002) 168:5699–5708.
   PubMed Web of Science ®Google Scholar
• BELLADONNA ML, RENAULD JC, BIANCHI R et al.: IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J. Immunol (2002) 168:5448–5454.
   PubMed Web of Science ®Google Scholar
• CUA DJ, SHERLOCK J, CHEN Y et al: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature (2003) 421:744–748.
   PubMed Web of Science ®Google Scholar
• •The first report using IL-23p19-deficient mice to demonstrate that IL-23 is vital for EAE development.
   Google Scholar
• WIEKOWSKI MT, LEACH MW, EVANS EW et al.: Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. Immunol (2001) 166:7563–7570.
   Web of Science ®Google Scholar
• LANGRISH CL, CHEN Y, BLUMENSCHEIN WM et al: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. (2005) 201:233–240.
   PubMed Web of Science ®Google Scholar
• ••The identification of IL-17 producing cellsto be the pathogenic T cell population in autoimmunity.
   Google Scholar
• ZIOLKOWSKA M, KOC A, LUSZCZYKIEWICZ G et al: High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. Immunol (2000) 164:2832–2838.
   Web of Science ®Google Scholar
• MURPHY CA, LANGRISH CL, CHEN Y et al.: Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. (2003) 198:1951–1957.
   PubMed Web of Science ®Google Scholar
• HARRINGTON LE, HATTON RD, MANGAN PR et al: Interleukin 17-producing CD4(÷) effector T cells develop via a lineage distinct from the T helper Type 1 and 2 lineages. Nat. Immunol (2005) 6:1123–1132.
   PubMed Web of Science ®Google Scholar
• ••These studies [91,92] demonstrate thatIL-17-producing T cells develop from a distinct TH precurser cell and show that TH1, as well as TH2 cytokines inhibit IL-17 production. The first report to provide a hypothesis as to why IFN-y and IL-12 appear to be beneficial in autoimmunity.
   Google Scholar
• PARK H, LIZ, YANG XO et al: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. (2005) 6:1133–1141.
   PubMed Web of Science ®Google Scholar
• GHILARDI N, KLJAVIN N, CHEN Q et al.: Compromised humoral and delayed- type hypersensitivity responses in IL-23-deficient mice. J. Immunol (2004) 172:2827–2833.
   PubMed Web of Science ®Google Scholar
• FERBER IA, BROCKE S, TAYLOR-EDWARDS C et al.: Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAR). Immunol (1996) 156:5–7.
   Web of Science ®Google Scholar
• AGGARWAL S, GHILARDI N, XIE MH, DE SAUVAGE FIGURNEY AL: Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. (2003) 278:1910–1914.
   PubMed Web of Science ®Google Scholar
• HOLSCHER C, ATKINSON RA, ARENDSE B et al.: A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol (2001) 167:6957–6966.
   PubMed Web of Science ®Google Scholar
• LI J, GRAN B, ZHANG GX et al: Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. ./. Neurol Sci. (2003) 215:95–103.
   PubMed Web of Science ®Google Scholar
• SEKI N, SUDO Y, YOSHIOKA T et al: Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol (1988) 140:1477–1484.
   Google Scholar
• STUART JM, DIXON FJ: Serum transferof collagen-induced arthritis in mice. Exp. Med. (1983) 158:378–392.
   PubMed Web of Science ®Google Scholar
• MAURI C, WILLIAMS RO, WALMSLEY M, FELDMANN M: Relationship between Thl/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. j Immunol. (1996) 26:1511–1518.
   PubMed Web of Science ®Google Scholar
• O'GARRA A, ARAI N: The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. (2000) 10:542–550.
   PubMed Web of Science ®Google Scholar
• PFLANZ S, TIMANS JC, CHEUNG J et al.: IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(÷) T cells. Immunity (2002) 16:779–790.
   PubMed Web of Science ®Google Scholar
• SMITS HH, VAN BEELEN AJ, HESSLE C et al: Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Thl development. Eur. Immunol (2004) 34:1371–1380.
   PubMed Web of Science ®Google Scholar
• PFLANZ S, HIBBERT L, MATTSON J et al.: WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27.1 Immunol (2004) 172:2225–2231.
   Google Scholar
• CHEN Q, GHILARDI N, WANG H et al: Development of Thl-type immune responses requires the Type I cytokine receptor TCCR. Nature (2000) 407:916–920.
   PubMed Web of Science ®Google Scholar
• YOSHIDA H, HAMANO S, SENALDI G et al:WSX-1 is required for the initiation of Thl responses and resistance to L. major infection. Immunity (2001) 15:569–578.
   Google Scholar
• VILLARINO AV, HUANG E, HUNTER CA: Understanding the pro- and anti-inflammatory properties of IL-27. Immunol (2004) 173:715–720.
   Web of Science ®Google Scholar
• TAKEDA A, HAMANO S, YAMANAKA A et al: Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Thl commitment. I Immunol (2003) 170:4886–4890.
   PubMed Web of Science ®Google Scholar
• LUCAS S, GHILARDI N, LI J, DE SAUVAGE FJ: IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Statl-dependent and -independent mechanisms. Proc. Nati Acad. Sci. USA (2003) 100:15047–15052.
   PubMed Web of Science ®Google Scholar
• OWAKI T, ASAKAWA M, MORISHIMA N et al: A role for IL-27 in early regulation of Thl differentiation. Immunol (2005) 175:2191–2200.
   Web of Science ®Google Scholar
• LI J, GRAN B, ZHANG GX, ROSTAMI A, KAMOUN M: IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. Neurof Sci. (2005) 232:3–9.
   PubMed Web of Science ®Google Scholar
• VANDENBROECK K, ALLOZA I, GADINA M, MATTHYS P: Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges. Pharm. Pharmacol. (2004) 56:145–160.
   PubMed Web of Science ®Google Scholar
• COSTA GL, SANDORA MR, NAKAJIMA A et al: Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. Immunol (2001) 167:2379–2387.
   Web of Science ®Google Scholar
• UYTTENHOVE C, ARENDSE B, STROOBANT V, BROMBACHER F, VAN SNICK J: Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection. Eur. Immunol (2004) 34:3572–3581.
   PubMed Web of Science ®Google Scholar
• HOLSCHER C: Targeting IL-23 in autoimmunity. Curr. Opin. Investig. Drugs (2005) 6:489–495.
   PubMedGoogle Scholar
• LANGRISH CL, MCKENZIE BS, WILSON NJ et al: IL-12 and IL-23: master regulators of innate and adaptive immunity. brununol. Rev (2004) 202:96–105.
   Google Scholar
• •This review discusses the role of IL-12 and IL-23 in innate and adaptive immunity.
   Google Scholar
• LIEBERIVL6iN LA, CARDILLO F, OWYANG AM et al: IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. brununol. (2004) 173:1887–1893.
   Google Scholar